S 100 protein is a 20 kDa calcium-binding protein widely distributed and conserved in the nervous system of vertebrates (Moore, 1965; Kessler et al., 1968; Calissano et al., 1969; Marks et al., 1983; Kuwano et al., 1984) . It is a hetero-or homodimer of two distinct, but similar subunits, SlOOa and SlOO/$ that have different tissue distributions Okuyama, 1978, 1981; Takahashi et al., 1984) . The BP-form of SlOO protein predominates in the mammalian brain, where it is found principally in the cytoplasm of astrocytes (Haan et al., 1982; Kato and Kimura, 1985; Zimmer and Van Eldik, 1987) . The presence of the protein in other locations in the brain is a subject of controversy. Early studies have reported the presence of SlOO protein in the nucleus of specific brainstem neurons (Hyden and McEwen, 1966; Sviridov et al., 1972) . Later studies have disputed a neuronal location for the protein (Matus and Mughal, 1975; Ghandour et al., 1981; Haan et al., 1982) .
S 100 protein accumulates during the maturation of the mammalian brain (Zuckerman et al., 1970; Cicero et al., 1972; Iandry et al., 1989) , and participates in several calcium-dependent interactions with other brain proteins (Pate1 and Marangos, 1972; Zimmer and Van Eldik, 1986; Baudier and Cole, 1988) . Although its localization is primarily cytoplasmic, SlOO protein has been also detected extracellularly in the CNS, suggesting that it may exert a paracrine or autocrine function following secretion from glial cells (Shashoua et al., 1984) . SlOO@ has been shown to stimulate growth in glia (Selinfreund et al., 199 1) and neurite extension in neurons (Kligman and Marshak, 1985; Kligman and Hsieh, 1987; Van Eldik et al., 1988; WinninghamMajor et al., 1989) in vitro. The above results have led to the suggestion that SlOOp may influence the development of the CNS by stimulating the proliferation of glia and differentiation of neurons Selinfreund et al., 199 1) .
We have recently cloned and characterized the full-length human gene for SlOOp ). This gene is composed of three exons, the first ofwhich specifies the 5' untranslated region, while the second and third each encode a single EFhand calcium-binding domain. The promoter region contains several potential regulatory elements of transcription, including CAMP-responsive elements and multiple repeats similar in sequence and location to the /3-globin direct repeat elements . The human SlOOfi gene has also been mapped to a subtelomeric location in the 2 1 q22. (Allore et al., 1988; Duncan et al., 1989; Burmeister et al., 199 1) . In order to develop a model to study the developmental consequences of an increased S 100/3 gene dosage, we have derived and characterized transgenic mice carrying multiple copies of the human SlOOp gene. These mice express human S lOO@ mRNA in a gene dose-dependent and tissue-specific manner, and higher than normal levels of S 1OOp protein in brain. Furthermore, by comparing the transgenic mice with their normal (nontransgenic) littermates using in situ hybridization and immunocytochemistry, we were able to localize S 1 OO@ precisely to astrocytes and a subset of brainstem neurons.
Materials and Methods
Trunsgene assembly. The transgene was derived from two overlapping human genomic clones (hHS 14.4 and hHS 100.1) (Fig. 1 ) that jointly span 25 kilobases (kb) of DNA including the S 1000 gene . Nonoverlapping fragments of the two clones were subcloned in multiple steps into PBS (Stratagene) to construct plasmid pWF9c containing 17.3 kb of human genomic DNA. In order to excise the transgene from pWF9c, the plasmid was cut at a ClaI site situated in the 5' polylinker (17 nucleotides upstream of the insert), and at a unique XbaI site situated at the 3' boundary of the insert. The resulting 17.3 kb ClaIXbaI genomic DNA fragment consisted of 7 kb of DNA spanning the three exons of the human SlOOp gene and 6.3 kb of the upstream and 4 kb of the downstream sequence. The fragment was purified by ultracentrifugation through a linear 10-40% sucrose gradient, precipitated with ethanol, and redissolved in H,O (Ausubel et al., 1987) .
Production of transgenic mice. The transgene was microinjected at a concentration of l-2 pg/ml into male pronuclei of fertilized CD 1 mouse eggs. The injected embryos surviving micromanipulation were reimplanted in the oviducts of pseudopregnant foster females, and allowed to develop to term according to published procedures (Hogan et al., 1986) . Hybridization probes. For Southern blotting, a 243 base pair partial human cDNA fragment, KN3 (encompassing most of the SlOOp coding region) , and an 0.8 kb partial rat cDNA fragment of the myelin-associated glycoprotein (MAG) (Arquint et al., 1987) were randomly labeled with o(-32P-dCTP. For Northern blotting, a 32P-CTPlabeled antisense riboprobe was derived from KN3 subcloned into an RNA synthesis vector, PBS (Stratagene), that had been linearized for in vitro transcription with BamHI. A )*P-CTP-labeled rat @actin antisense riboprobe was derived as previously described (Dunn et al., 1987) .
For in situ hybridization, the following YS-ladeled probes were used. Antisense riboprobes labeled with 35S-UTP were derived from (1) the human S 1000 EDNA clone KN3 described above, (2) a rat S 1008 $NA clone (Dunn et al., 1987) subcloned into pSP65 (Promega) and linearized with BamHI, and (3) exon 1 of the mouse neurofilament light chain gene (Lewis and Cowan, 1986 ) subcloned into pGEM-3Z (Promega) and linearized with BglII. Sense riboprobes were similarly derived after linearization of the vectors with appropriate restriction enzymes. A synthetic antisense 34 base oligonucleotide, spanning the (exon 1) sequence + 2 1 to + 54 of the human S 1000 gene, was end labeled with 35S-ATP. This probe is complementary to 34 nucleotides of the 5' untranslated region of the human S 1008 mRNA. Preparation and Southern blotting of DNA. DNA was prepared from mouse tail clippings as described in the literature (Hogan et al., 1986) . Samples of DNA (5 pg) were digested with restriction enzymes, fractionated on 1% agarose gels, and blotted onto nylon membranes (Zetaprobe, Bio-Rad). Southern blotting was performed essentially as described previously (Allore et al., 1988) , using a mixture of 3ZP-labeled human S 1 OOP and rat MAG cDNA probes. The blots were exposed to preflashed x-ray film (Kodak X-Omat, AR) with an intensifying screen at -70°C. The number of human S 1 OOP gene copies in mice from each ofthe transgenic lines was determined by densitometry and comparison with a human diploid placental DNA standard. Densitometry was performed on a Molecular Dynamics computing densitometer model 300A using the Molecular Dynamics IMAGE QUANT software release version 3.0. Preparation and Northern blotting of RNA. Mice were anesthetized and killed by cervical dislocation. Brain and other organs were rapidly removed, rinsed in phosphate-buffered saline (PBS; 140 mM NaCl, 3 mM KCl, 8 mM Na,HPO,, 1.5 mM KH,PO,, pH 7. l), frozen in liquid nitrogen, and powdered. RNA was prepared from powdered tissue by homogenization in 4 M guanidinium isothiocyanate and centrifugation through a cushion of cesium chloride (Sambrook et al., 1989) . Northern blotting was performed essentially as described previously (Dunn et al., 1987) , using a 32P-labeled human SlOOfl antisense riboprobe (KN3). Blots were exposed to x-ray film and the relative amounts of SlOOp mRNA were determined by densitometry as described above. In order 1.6 kb-1.0 kb- Figure 2 . Tissue-specific expression of SlOO@ mRNA in transgenic mice. Total RNA (10 pg per lane) was analyzed by Northern blotting, using a j2P-labeled human SlOOp antisense riboprobe KN3. RNA from the following sources was analyzed in the specified individual lanes: transgenic mouse (line H-2) brain (I), liver (2), heart (3), kidney (4); human brain (5); rat glioma (C6) cells (6); normal mouse brain (7). The positions of migration of human S 1 OOP mRNA ( 1 .O kb) and mouse and I 2 3 4 5 6 7 ed.
rat SlOO@ mRNA (1.6 kb) are indicatto control for equivalent loading of RNA, the blots were rehybridized with a s2P-labeled rat fi-actin probe, reexposed to x-ray film, and analyzed by densitometry.
In situ hybridization. The analysis of 15 pm cryostat sections of mouse brains for expression of mouse and human S 1 OOP mRNA and of neurofilament light chain mRNA using in situ hybridization with appropriate YS-labeled antisense riboprobes was performed as previously described (Landry'et al., 1989) . Alternate sections were hybridized with an equal amount of control YS-labeled sense riboprobe. Nontransgenic littermates were used as controls for the transgenic mice. The following modifications were instituted when the 34 base oligonucleotide probe complementary to part of the 5' untranslated human S 1 OO@ mRNA sequence was used. First, digestion of sections with proteinase K to facilitate probe penetration was not carried out. Second, hybridization temperature was lowered to 50°C from 55°C. Third, digestion with RNase A was omitted. Fourth, the final wash in 0.1 x saline-sodium citrate, 300 mM 2-mercaptoethanol was performed at 60°C instead of 70°C.
Following hybridization and washing, the sections were applied to Du Pont Cronex sensitive x-ray film or coated with Kodak NTB2 liquid emulsion, and exposed for varying periods of time. The slides were developed in Kodak D 19 developer for 2.5 min and stained lightly with cresyl violet.
Western blotting of brain extracts for SlOO@ protein. Mouse brains were obtained as described above. Brain extracts were prepared from frozen brain powder as described previously , except that 2-mercaptoethanol was omitted from all buffers, and assayed for protein concentration (Lowry et al., 195 1) . Aliquots of the 100,000 x g supematants were dissociated by boiling in the presence of 2% SDS, 5% 2-mercaptoethanol and subjected to electrophoresis in 12.5% polyacrylamide slab gels in the presence of 0.1% SDS and 2 mM EDTA. The gels were frozen at -70°C and soaked in transfer buffer (12.5 mM Tris HCl, 96 mM glycine) for 30 min to remove the SDS, and the proteins were transferred electrophoretically to polyvinyl membranes (Immobilon-P, Millipore).
The blots were incubated at room temperature, first for 2 hr with PBS containing 10% skim milk to block nonspecific binding of antibody, and then for 1 hr with anti-S100 protein monoclonal antibody G12.B8 (Haan et al., 1982 ; a generous gift from Dr. B. Boss, Salk Institute) at a 1:2000 dilution in PBS containing 1% skim milk, and finally washed three times for 30 min each with PBS containing 0.02% Tween 20. Following washing, the blots were incubated for 1 hr at room temperature with peroxidase-conjugated rabbit anti-mouse Ig antibody (Dako; 1:500 dilution) and washed as described above, and the peroxidase color reaction was developed by addition of substrate (1% diaminobenzidine in PBS containing 0.009% H,O, for l-2 min). After visualization of the SlOO@ band, the membranes were incubated with 12s1-nrotein A (2 x lo5 corn/ml in PBS containina 1% skim milk) for 2 hr at room temperature, washed as described abode, and analyzed by autoradiography as described above for Southern blotting.
Immunohistochemistry. Immunoperoxidase staining of mouse brain, liver, heart, and kidney sections for localization of S 1 OO@ was performed as previously described (Kahn et al., 1983; Nakamura et al., 1983) , except that an indirect immunoperoxidase technique was used. The organs were fixed in 10% formalin, embedded in paraffin, and cut at 6 pm sections. The sections were deparaffinized with xylol, washed in three changes of absolute ethanol, and incubated with 0.3% H,O, in methanol to inactivate endogenous peroxidase. Incubations with various sera and antisera were at room temperature in a humidified chamber. Between each incubation, the sections were washed with 5 mM Tris HCl, pH 7.4, containing 145 mM NaCl (TBS). Normal swine serum was applied at a 1: 10 dilution in TBS for 10 min, followed by rabbit antiSlOO protein antibody (Labourdette and Marks, 1975 ) at a 1:400 dilution or rabbit anti-neuron-specific enolase antibody (Dako) at a 1:250 dilution, for 60 min. The rabbit anti-S100 protein antibody reacts with SlOOg but not SlOOcv (Kahn et al., 1991) . Secondary antibody (peroxidase-conjugated swine anti-rabbit Ig antibody at a 1:20 dilution) was applied for 30 min. The peroxidase color reaction was developed by the addition of 0.05% diaminobenzidine and 0.02% H,O, in TBS for 5 min. The sections were counterstained with hematoxylin, dehydrated, cleared, and mounted.
Results

Generation of transgenic mice
The transgene consisted of a 17.3 kb human genomic DNA ClaI-XbaI fragment containing the three exons of the SlOOp gene, 6.3 kb of DNA 5' to the transcription initiation site, and 4 kb of DNA 3' to the polyadenylation signal (Fig. 1) . Previous studies have demonstrated that this fragment contains the control elements required for accurate transcription of the human Sloop gene in transfected rat glioma cells ). Values for human SlOO@ mRNA were obtained from densitometry of Northern blots, and are expressed as relative amounts to the value obtained for brain, which was arbitrarily set at 100. Results shown are averages of two determinations performed on one mouse from each transgenic line.
The fragment was injected into male pronuclei of fertilized CD 1 mouse eggs, and the surviving embryos were reimplanted in the oviducts of pseudopregnant foster females and allowed to develop to term. Offspring were screened for transgene incorporation by Southern blotting of tail DNA with a human S 1 OOp specific probe. Eight founder transgenics, three males and five females, were identified. One founder male died 3 weeks after birth. Of the remaining founder mice, one of two males and two of five females failed to transmit the transgene to the Fl progeny, Suggesting that these mice were mosaics that had not incorporated the transgene into the germline. The other male The blots were exposed to x-ray film for 5 d at -70°C. The blots were rehybridized with a )*P-labeled rat @-actin antisense probe, and reexposed to x-ray film for 20 hr. B is a composite of the two autoradiograms.
The positions of migration of mouse @actin mRNA ( 1.8 kb), mouse S 1 OO(3 mRNA (1.6kb),andhumanSlOO~mRNA(l.O kb) are indicated. C, Western blotting was performed on brain extracts (4 llg/ lane) following separation by SDS-PAGE under reducing conditions. The primary antibody used was mouse monoclonal anti-S1 00 protein antibody, followed by rabbit anti-mouse Ig antibody, and 12Sl-protein A. The position of migration of Sl 000 protein (M, 1OK) is indicated. The origin of the DNA, RNA, and protein samples in the respective lanes is the following: transgenie lines H-2 (lanes 1 and 2), H-8 (lanes 3 and 4), H-5 (lanes 5 and 6), H-4 (lanes 7 and 8), control (nontransgenie) mouse (lane 9), human (lane IO). DNA, RNA, and protein samples were from the same individual mouse in each of the respective lanes 1-9. and three females were successfully crossed with CD1 mice to generate four transgenic lines H-2, H-8, H-5, and H-4. Mice from these lines carried approximately 110,70,8, and 10 copies of the transgene, respectively (see below).
Tissue-specijic expression of SI 00/3 mRNA in transgenic mice On Northern blots, the human S 1OOp antisense riboprobe KN3, which covers the evolutionarily conserved SlOOB coding sequence, hybridized to the human S 100/3 mRNA of 1 .O kb and the mouse and rat S 100/I mRNAs of 1.6 kb (Fig. 2) in agreement with the sizes of human and rat S 1 OO@ mRNA species that have been reported previously (Dunn et al., 1987; . The size difference between the human and mouse S 1 OOP mRNA species allowed identification of transcripts from the human SlOOp transgene in the presence of the endogenous cross-hybridizing mouse transcript. Both the 1.0 kb and 1.6 kb mRNA species were present in transgenic mouse brain. The human Sl OOp mRNA (1 .O kb) was present in high amounts in brain and was detected in only very low amounts (lo-50-fold less) in liver, heart, and kidney. The endogenous mouse mRNA (1.6 kb) was present in brain but was not detected in liver, heart, or kidney. The relative amounts of human SlOOp mRNA present in the brain, liver, heart, and kidney in each of the transgenic cell lines are shown in Table 1 noreactive histiocytes were seen (data not shown). Other minor cell types that likely contribute to the low level of human S 1 OOp mRNA expression in these organs include Schwann cells that surround the innervating nerve fibers (Kahn et al., 1991) . The precise localization of SlOO/3 in cell types outside the CNS is presently under investigation in the transgenic mouse lines.
Dosage-dependent expression of the human SIOOP gene in transgenic mice
The results of Southern blot analysis of tail DNA, Northern blot analysis of brain RNA, and Western blot analysis of brain extracts of mice from each of four transgenic lines are shown in Figure 3 . On Southern blotting (Fig. 3A) , the rat MAG and human SlOOp cDNA probes hybridized to 4.4 kb and 3.2 kb EcoRI fragments, respectively. At the stringency conditions used, the human S 1 OOP cDNA probe hybridized to human placental DNA (Fig. 3A , lane 10) but not to control (nontransgenic) mouse DNA (lane 9). The signal obtained with the MAG probe was used to correct for loading differences in the DNA samples from the transgenic mice for estimation of gene copy number from densitometric analysis. On Northern blotting (Fig. 3B ), the rat P-actin antisense probe hybridized to a 1.8 kb mRNA species, and the human SlOOp (KN3) antisense probe, to a 1.6 kb mouse S 1 OO@ mRNA and a 1 .O kb human SlOOp mRNA species. Both SlOO@ mRNA species were present in transgenic mouse brain. The human S 1 OO@ mRNA signal was much stronger than the mouse S 1 OOp mRNA signal. In addition, a minor hybridizing band was also seen below the mouse S 1008 mRNA in the high transgene copy lines H-2 and H-8 (Fig. 3B, lanes l-4) . This band likely represents a minor transcript of the human SlOOp transgene. The signal obtained with the actin probe was used to correct for the loading differences in the RNA from the transgenic mice for estimation of relative amounts of S 1 OOP mRNA from densitometric analysis. The strength of the human S 1 OOP mRNA signal on Northem blots increased in parallel with the human S 1 OOP gene signal on Southern blots, suggesting a direct correlation between human S 1 OOp gene copy number and the amount of human S 1 OOp mRNA in the brain of mice from each of the four transgenic lines. In contrast, the mouse SlOOp mRNA signal did not vary appreciably among the brains of these mice. On the basis of densitometric analysis, the mean amount of mouse S 100/3 mRNA in the brain of the eight transgenic mice shown in Figure 3B represented 0.14 + 0.05 ( f SD) of the amount of human S 1 OOP mRNA in the brain of transgenic mice with the lowest human SlOOp gene copy number (line H-5). This correlates well with the average number of human transgene copies (eight) present in this cell line.
On Western blotting (Fig. 3C ), S 1 OOP protein from transgenic mouse, normal mouse, and human brain migrated with an M, of 10,000 in SDS-PAGE under reducing conditions, in the same position as that of the subunits of purified bovine brain SlOO protein (not shown). In general, there was good agreement between the strengths of the S 100/3 mRNA signal on Northern blots and the corresponding SlOOp protein signal on Western blots for individual mice from the four transgenic lines, suggesting a direct correlation between levels of human SlOOp mRNA and the corresponding levels of the translated protein.
The relationship between transgene copy number and levels of human SlOOp mRNA in the four transgenic lines is shown in Figure 4 . The levels of human SlOOp mRNA increased directly with increased transgene copy number. Regional distribution of SlOO/3 mRNA in normal and transgenic mouse brain determined by in situ hybridization Brain regions that express SlOOp mRNA were identified by in situ hybridization (Fig. 5 ) using a rat SlOOP antisense riboprobe in normal mice (Fig. 5A,D,G) , and a 34 base human antisense oligonucleotide probe complementary to part of the 5' untranslated region of human SlOO@ mRNA in transgenic mice (Fig. 
SB,E,H). The oligonucleotide probe was specific for human
Sloop mRNA and did not hybridize with mouse mRNA in normal mouse brain (Fig. 5C,F,Z) . The distribution of mouse and human Sloop mRNA in normal and transgenic mouse brain, respectively, was remarkably similar. At low magnification (Fig. 5A,B) , SlOOp mRNA was found to be concentrated in specific brain regions such as cerebellum and defined brainstem nuclei including the mesencephalic and motor trigeminal, facial, and lemniscus. Focusing on the cerebellum at higher magnification (using dark-field microscopy) (Fig. 5D,E) , S 1 OOP mRNA was found in the molecular cell layer and deep white matter, but not in the granule cell layer. At a still higher magnification of the Purkinje cell layer (Fig. 5G,H) , the signal corresponding to S 1 OOP mRNA was localized over Bergmann glia situated between Purkinje neurons. This localization was particularly well defined in the transgenic mouse brain because of the high amount of the human SlOOp mRNA (Fig. 5H) . 
Expression of SIOOP mRNA and protein in discrete neuronal populations
In order to examine the possibility that SlOOp mRNA was expressed in discrete neuronal populations in brainstem nuclei, the pattern of hybridization obtained using a neuronal marker probe (mouse neurofilament light chain antisense riboprobe) was compared with that obtained using the rat S 1 OOP antisense riboprobe (Fig. 6) . In normal mice, the patterns were very similar over the trigeminal and facial nuclei (Fig. 6A,B) . When consecutive sections of the mesencephalic trigeminal nucleus were probed with the Sloop (Fig. 6C) or neurofilament (Fig.  60) probes, the signals appeared to be localized over identical cells, suggesting that discrete brainstem neurons express S 1 OOp mRNA. Likewise, in transgenic mice, the pattern of labeling over the facial nucleus in a section hybridized with the human S 1 OOp antisense riboprobe (KN3) (Fig. 6E) , was very similar to that in an adjacent section hybridized with the neurofilament probe (Fig. 6F) . At the stringency conditions used for in situ hybridization, KN3 did not hybridize to sections of normal mouse brain (Fig. 6G,H) . There was no hybridization signal above background with any of the control sense riboprobes.
In order to correlate regional and cellular expression of S 1 OOp mRNA with protein, sections of normal and transgenic mouse brain were examined for the presence of SlOOp protein by immunoperoxidase staining using a rabbit anti-S 100 protein polyclonal antibody (Fig. 7) . In all regions and cell types examined, staining was more intense in transgenic mice (Fig. 7B,D,F' ), than in normal mice (A, C, E). S 1 OOp protein was present in individual astrocytes in hippocampus (Fig. 7A,B) , in Bergmann glia between Purkinje neurons in cerebellum (Fig. 7C,D) , and discrete neurons in brainstem (Fig. 7E,F) . In normal mice, positive staining was confined to the nucleus of selected brainstem neurons. In the same regions of brainstem in transgenic mice, staining was of much greater intensity and involved both the nucleus and cytoplasm of neurons. Additional confirmation of the neuronal cell type was provided by Bielschowsky staining (Fig. 7G) and positive immunoperoxidase staining with antibody to neuron-specific enolase (Fig. 7H ), but absence of staining with antiglial fibrillary acidic protein antibody (not shown).
The agreement between the results of in situ hybridization and immunoperoxidase staining indicates a concordance between expression of SlOOp mRNA and production of SlOO@ protein, suggesting that the protein is synthesized in the cells where it is found and not taken up after secretion from other sources. Moreover, the pattern of increased SlOOp immunoreactivity in astrocytes and neurons was similar in brains of mice from each of the four transgenic lines, indicating that there 
Discussion
Presence of a locus control region in the human SIOOP gene In many transgenic mouse studies, expression from the inserted transgene has been found to vary among lines derived from different founder animals. In addition, expression from the transgene often did not correlate with the transgene copy number and was at a much lower level than expression from the endogenous homolog (Palmiter and Brinster, 1986) . These quantitative differences are believed to reflect a position effect resulting from random integration of the transgene into the mouse genome (Palmiter and Brinster, 1986) . Locus control regions (LCRs) (Stamatoyannopoulos, 199 1) that circumvent these limitations have been identified in the flanking regions of a number of human genes including @globin and CD2 (Grosveld et al., 1987; Greaves et al., 1989) . Similarly, introduction of the 17.3 kb SlOOp gene fragment into transgenic mice resulted in a position-independent, copy number-dependent, expression of both S 1008 mRNA and S 1 OOP protein. Even though gene expression increased to levels IO-loo-fold above normal, tissue and cell specificity were maintained. Expression of human S lOO@ mRNA in liver, heart, and kidney was detected at levels lO-50-fold lower than that observed in brain, and there was no SlOOp immunoreactivity in the parenchymal cells in any of these (nonbrain) organs. These results suggest that a sequence within the 17.3 kb fragment functions as an LCR in a manner analogous to the LCR described for the human &lobin gene (Grosveld et al., 1987) . The P-globin LCR has been shown to activate both @globin and heterologous genes in transgenic mice in a gene copy-dependent, erythroid-specific manner, independent of the . In E, immunoreactivity is confined to neuronal nuclei, and in F, it is present in both neuronal nuclei and cytoplasm. G and Hare brainstem regions of a normal mouse showing neurons stained with Bielschowsky stain (G) or with rabbit anti-neuronspecific enolase antibody(H).
Scale bar: A-D, 200 pm; E-H, 100 Frn. site of transgene insertion (Grosveld et al., 1987; Blom van Assendelft et al., 1989) . These unique gene-regulating properties appear to be due to two activities of the globin LCR, a chromatin domain organizing activity indicated by the appearance of DNase I-sensitive regions, and a transcription enhancer activity (Behringer et al., 1990; Collis et al., 1990) . A similar activity, manifested in the CNS, particularly in astrocytes and selected brainstem neurons, appears to reside in the SlOO@ gene fragment studied here. Sites of DNase I sensitivity may provide useful markers for the location of the SlOOp LCR, and an approach to the characterization of the specific LCR sequence.
Localization of SIOOP in brain Our in situ hybridization and immunocytochemistry experiments clarify a number of long-standing issues relating to the precise location of S 100 protein in brain. The finding of S 1 OOP in astrocytes (Bergmann glia) in cerebellum and hippocampus is in agreement with published data (Matus and Mughal, 1975; Haan et al., 1982) . On the other hand, the previously reported presence of SlOO protein in the nucleus of discrete brainstem neurons has been the subject ofcontroversy (Hyden and McEwen, 1966; Ghandour et al., 198 1) . Because of the nuclear location, a possible role for S 100 protein in the control of gene expression was proposed (Hyden and McEwen, 1966) . However, it was not known whether these neurons synthesized SlOO protein or the protein was taken up by neurons after being produced and secreted by astrocytes (Hyden and McEwen, 1966) . Our results indicate that since both SlOOp mRNA and SlOOp protein are present in selected neuronal populations, these cells actually synthesize S 1 OOp.
The origin of the S 1 OOP-expressing neurons in brainstem nuclei is not known. A presumptive common precursor for neuronal and glial cell lineage has been described in the prenatal mouse hypothalamus (De Vitry et al., 1980) . This bipotential stem cell expresses SlOO protein and could give rise to both neuronal and glial cell populations in which this protein is found.
Functional implications of increased Sl OOP levels Our model compares favorably with the other transgenic mouse models derived to study the conseauences ofaberrant expression of individual genes located on chromosome 21 in humans. In the case of superoxide dismutase, there was no correlation between the number of integrated human gene copies and the observed level of gene expression, and the tissue distribution of the human enzyme differed from that of the product of the endogenous mouse gene (Epstein et al., 1987) . Some transgenic mice in that study developed abnormalities in the neuromuscular junctions of the tongue resembling those seen in Down's syndrome subjects (Avraham et al., 1988) . These abnormalities were age dependent, and nontransgenic littermates developed similar findings at a more advanced age (Avraham et al., 1988) . In the case of the human &amyloid protein gene, the transcript of the human transgene represented only a small fraction of the transcript of the endogenous mouse gene in one study (Wirak et al., 199 l) , and there was no apparent correlation between the integrated human gene copy number and the level of the expressed gene product in the other study (Quon et al., 199 1) . In the latter study, amyloid deposition was found in the brain of the transgenic mice, but no behavioral abnormalities were reported. In contrast, in the present study, the human S 1 OOP transgene was expressed at high levels in a copy number-dependent and cell-specific manner. The increased immunoreactivity of S 1000 protein in individual astrocytes in the brain of transgenic mice mimics the increased S 100 protein immunoreactivity observed in the brains of Down's syndrome and Alzheimer disease subjects (Griffin et al., 1989) . Nonetheless, transgenic mice from each of the four lines did not manifest any obvious behavioral differences or gross pathological abnormalities at autopsy in comparison with their normal littermates. This implies that excessive expression of the SlOOp gene ranging from approximately lo-to loo-fold over normal is generally well tolerated, but does not exclude the possibility that increased levels of S 100/3 promote subtle changes in development or behavior that will become apparent in more precise histological and functional assays.
